Prospective non-interventional cohort study to assess safety and tolerability of 3Fluart 2023/2024 trivalent seasonal influenza vaccine in children, adolescents, adults and elderly subjects (3Fluart-H-34)

First published 24/05/2023

Last updated 02/05/2024

EU PAS number:

EUPAS105039

Study

Finalised

Download as PDF

Documents

Study protocol

No information provided.

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

Prospective non-interventional cohort study to assess safety and tolerability of 3Fluart 2023/2024 trivalent seasonal influenza vaccine in children, adolescents, adults and elderly subjects (3Fluart-H-34)

Secondary tabs

Share this page